Transient Inhibition of TrkB Kinase after Status Epilepticus Prevents Development of Temporal Lobe Epilepsy

Neuron

Volumn 79, Issue 1, 2013, Pages 31-38

  Liu, Gumei ^a,d   Gu, Bin ^a   He, Xiao Ping ^a   Joshi, RaseshB ^b   Wackerle, HaroldD ^c   Rodriguiz, RamonaMarie ^a   Wetsel, WilliamC ^a   McNamara, JamesO ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke University   (United States)

^c Duke University   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,1 DIMETHYLETHYL) 3 (1 NAPHTHALENYLMETHYL) 1H PYRAZOLO[3,4 D]PYRAMIDIN 4 AMINE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIAZEPAM; ENZYME INHIBITOR; KAINIC ACID; LORAZEPAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVATION; ENZYME INHIBITION; EPILEPTIC STATE; EPILEPTOGENESIS; FEMALE; HIPPOCAMPUS; INTRACELLULAR SIGNALING; MALE; MOUSE; NERVE CELL LESION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECURRENT DISEASE; TEMPORAL LOBE EPILEPSY; TREATMENT DURATION; TREATMENT OUTCOME;

AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; KAINIC ACID; MICE; MOTOR ACTIVITY; NEURONS; RECEPTOR, TRKB; SIGNAL TRANSDUCTION; STATUS EPILEPTICUS;

EID: 84880040607     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.04.027     Document Type: Article

References (32)

1. Alldredge B.K., Gelb A.M., Isaacs S.M., Corry M.D., Allen F., Ulrich S., Gottwald M.D., O'Neil N., Neuhaus J.M., Segal M.R., Lowenstein D.H. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N.Engl. J. Med. 2001, 345:631-637.
2. Annegers J.F., Hauser W.A., Shirts S.B., Kurland L.T. Factors prognostic of unprovoked seizures after febrile convulsions. N.Engl. J. Med. 1987, 316:493-498.
3. Ben-Ari Y., Tremblay E., Ottersen O.P. Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience 1980, 5:515-528.
4. Beyenburg S., Mitchell A.J., Schmidt D., Elger C.E., Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005, 7:161-171.
5. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., Dingledine R. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp. Neurol. 2003, 182:21-34.
6. Boulle F., Kenis G., Cazorla M., Hamon M., Steinbusch H.W., Lanfumey L., Van Den Hove D.L. TrkB inhibition as a therapeutic target for CNS-related disorders. Prog. Neurobiol. 2012, 98:197-206.
7. Bourin M., Hascoët M. The mouse light/dark box test. Eur. J. Pharmacol. 2003, 463:55-65.
8. Cascino G.D. Structural brain imaging. Epilepsy: A Comprehensive Textbook 1998, 937-946. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
9. Chen X., Ye H., Kuruvilla R., Ramanan N., Scangos K.W., Zhang C., Johnson N.M., England P.M., Shokat K.M., Ginty D.D. A chemical-genetic approach to studying neurotrophin signaling. Neuron 2005, 46:13-21.
10. Engel J., Williamson P., Wieser H.-G. Mesial temporal lobe epilepsy. Epilepsy: A Comprehensive Textbook 1998, 2417-2426. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
11. Ferreira, T., and Rasband, W. (2011). The ImageJ User Guide. http://rsbweb.nih.gov/ij/docs/user-guide.pdf.
12. French J.A., Williamson P.D., Thadani V.M., Darcey T.M., Mattson R.H., Spencer S.S., Spencer D.D. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann. Neurol. 1993, 34:774-780.
13. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 1969, 25:295-330.
14. Gröticke I., Hoffmann K., Löscher W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp. Neurol. 2007, 207:329-349.
15. Helgager J., Liu G., McNamara J.O. The cellular and synaptic location of activated TrkB in mouse hippocampus during limbic epileptogenesis. J.Comp. Neurol. 2013, 521:499-521. Spc1.
16. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2003, 72:609-642.
17. Huang X., Zhang H., Yang J., Wu J., McMahon J., Lin Y., Cao Z., Gruenthal M., Huang Y. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol. Dis. 2010, 40:193-199.
18. Jimenez-Mateos E.M., Engel T., Merino-Serrais P., McKiernan R.C., Tanaka K., Mouri G., Sano T., O'Tuathaigh C., Waddington J.L., Prenter S., et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat. Med. 2012, 18:1087-1094.
19. Kotloski R., Lynch M., Lauersdorf S., Sutula T. Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog. Brain Res. 2002, 135:95-110.
20. Lehmkuhle M.J., Thomson K.E., Scheerlinck P., Pouliot W., Greger B., Dudek F.E. A simple quantitative method for analyzing electrographic status epilepticus in rats. J.Neurophysiol. 2009, 101:1660-1670.
21. Mathern G.W., Babb T.L., Armstrong D.L. Hippocampal sclerosis. Epilepsy: A Comprehensive Textbook 1998, 133-156. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
22. McClelland S., Flynn C., Dubé C., Richichi C., Zha Q., Ghestem A., Esclapez M., Bernard C., Baram T.Z. Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann. Neurol. 2011, 70:454-464.
23. Mouri G., Jimenez-Mateos E., Engel T., Dunleavy M., Hatazaki S., Paucard A., Matsushima S., Taki W., Henshall D.C. Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res. 2008, 1213:140-151.
24. Paradiso B., Marconi P., Zucchini S., Berto E., Binaschi A., Bozac A., Buzzi A., Mazzuferi M., Magri E., Navarro Mora G., et al. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc. Natl. Acad. Sci. USA 2009, 106:7191-7196.
25. Pitkänen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia 2010, 51(Suppl 3):2-17.
26. Pitkänen A., Narkilahti S., Bezvenyuk Z., Haapalinna A., Nissinen J. Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res. 2004, 61:119-140.
27. Rattiner L.M., Davis M., French C.T., Ressler K.J. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J.Neurosci. 2004, 24:4796-4806.
28. Segal R.A., Bhattacharyya A., Rua L.A., Alberta J.A., Stephens R.M., Kaplan D.R., Stiles C.D. Differential utilization of Trk autophosphorylation sites. J.Biol. Chem. 1996, 271:20175-20181.
29. Torta R., Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia 1999, 40(Suppl 10):S2-S20.
30. Tsai M.H., Chuang Y.C., Chang H.W., Chang W.N., Lai S.L., Huang C.R., Tsai N.W., Wang H.C., Lin Y.J., Lu C.H. Factors predictive of outcome in patients with de novo status epilepticus. QJM 2009, 102:57-62.
31. Wang H., Shimizu E., Tang Y.P., Cho M., Kyin M., Zuo W., Robinson D.A., Alaimo P.J., Zhang C., Morimoto H., et al. Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc. Natl. Acad. Sci. USA 2003, 100:4287-4292.
32. Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia 2010, 51:27-36.